Myles Minter William Blair Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
7
Avg Return
Past Year
Past Year
86%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
37.5%
Neutral
62.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| – | – | 2 | +13% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Outperform
Upgraded
| – | – | 1 | -6.9% |
0
%
| 17 Feb ‘26 2 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | – |
–
| 5 Nov ‘25 5 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | – |
–
| 22 Oct ‘25 6 months ago |
|
|
|
Outperform
Initiated
| – | – | 1 | +338% |
0
%
| 2 Jul ‘25 9 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | – |
–
| 17 Jun ‘25 10 months ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | – |
–
| 22 May ‘25 11 months ago |
|